Aadi Bioscience (AADI) Competitors

Akoya Biosciences (NASDAQ:AKYA) and Aadi Bioscience (NASDAQ:AADI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, community ranking, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

Do analysts recommend AKYA or AADI?

Akoya Biosciences presently has a consensus price target of $7.79, suggesting a potential upside of 262.13%. Aadi Bioscience has a consensus price target of $20.50, suggesting a potential upside of 1,038.89%. Given Akoya Biosciences' higher possible upside, analysts clearly believe Aadi Bioscience is more favorable than Akoya Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Akoya Biosciences	0 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.88
Aadi Bioscience	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Does the media prefer AKYA or AADI?

In the previous week, Akoya Biosciences and Akoya Biosciences both had 4 articles in the media. Aadi Bioscience's average media sentiment score of 0.82 beat Akoya Biosciences' score of 0.53 indicating that Akoya Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Akoya Biosciences	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aadi Bioscience	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals hold more shares of AKYA or AADI?

79.4% of Akoya Biosciences shares are held by institutional investors. Comparatively, 52.1% of Aadi Bioscience shares are held by institutional investors. 7.3% of Akoya Biosciences shares are held by insiders. Comparatively, 37.3% of Aadi Bioscience shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Does the MarketBeat Community favor AKYA or AADI?

Akoya Biosciences received 17 more outperform votes than Aadi Bioscience when rated by MarketBeat users. Likewise, 60.87% of users gave Akoya Biosciences an outperform vote while only 47.83% of users gave Aadi Bioscience an outperform vote.

Company	Underperform	Outperform
Akoya Biosciences	Outperform Votes 28 60.87%	Underperform Votes 18 39.13%
Aadi Bioscience	Outperform Votes 11 47.83%	Underperform Votes 12 52.17%

Which has higher valuation and earnings, AKYA or AADI?

Akoya Biosciences has higher revenue and earnings than Aadi Bioscience. Akoya Biosciences is trading at a lower price-to-earnings ratio than Aadi Bioscience, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Akoya Biosciences	$96.63M	1.10	-$63.32M	-$1.47	-1.46
Aadi Bioscience	$24.35M	1.81	-$65.76M	-$2.55	-0.71

Which has more volatility & risk, AKYA or AADI?

Akoya Biosciences has a beta of 1.52, meaning that its share price is 52% more volatile than the S&P 500. Comparatively, Aadi Bioscience has a beta of 0.64, meaning that its share price is 36% less volatile than the S&P 500.

Is AKYA or AADI more profitable?

Akoya Biosciences has a net margin of -72.68% compared to Akoya Biosciences' net margin of -288.72%. Akoya Biosciences' return on equity of -61.83% beat Aadi Bioscience's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Akoya Biosciences	-72.68%	-111.80%	-35.13%
Aadi Bioscience	-288.72%	-61.83%	-51.52%

Summary

Akoya Biosciences beats Aadi Bioscience on 12 of the 17 factors compared between the two stocks.